W Birkmayer

Statistics

Publications

Citations

5.3K

H-Index

Active since

1962

Affiliations

Ludwig Boltzmann Institute for Digital Health and Prevention(Current)

Ludwig Boltzmann für Klinische Neurobiologie

Ludwig Boltzmann Institut für Epilepsie und Neuromuskuläre Erkrankungen

Technion – Israel Institute of Technology

Klinik Hietzing

W Birkmayer is an author at Ludwig Boltzmann Institute for Digital Health and Prevention specializing in parkinson disease, parkinsonian disorders, and medicine.

Publications per year

1962–2015

Publications

Brain dopamine and the syndromes of Parkinson and Huntington Clinical, morphological and neurochemical correlations

H. Bernheimer, W Birkmayer, Oleh Hornykiewicz et al. · Journal of the Neurological Sciences · 1973 · 2.7K citations

Life Sciences, Neurology, Neuroscience +16

Increased life expectancy resulting from addition of l-deprenyl to Madopar� treatment in Parkinson's disease: A longterm study

W Birkmayer, J. Knoll, Peter Riederer et al. · Journal of Neural Transmission · 1985 · 436 citations

Medicine, Neurology, Pharmacology +10

The potentiation of the anti akinetic effect after L-Dopa treatment by an inhibitor of Mao-B, deprenil

W Birkmayer, Peter Riederer, Moussa B. H. Youdim et al. · Journal of Neural Transmission · 1975 · 362 citations

Medicine, Pharmacology, Pharmacotherapy +11

IMPLICATIONS OF COMBINED TREATMENT WITH 'MADOPAR' AND L-DEPRENIL IN PARKINSON'S DISEASE

W Birkmayer, Peter Riederer, L Ambrozi et al. · The Lancet · 1977 · 296 citations

Medicine, Neurology, Pharmacotherapy +12

(-)-Deprenyl Leads to Prolongation of L-Dopa Efficacy in Parkinson�s Disease

W Birkmayer, J. Knoll, Peter Riederer et al. · Modern problems of pharmacopsychiatry/Modern trends in pharmacopsychiatry · 2015 · 135 citations

Medicine, Neuroscience, Pharmacology +13

1–5 of 39